Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.398EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.398ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.398ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.398EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.398EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.398ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.398ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.163EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.163ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.163EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.163EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.163ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.3 (Theta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.3 (Theta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.3 (Theta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.3 (Theta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.3 (Theta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.3 (Theta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.38.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.38.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.38.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.2.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.2.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used